MYPOP
gene geneOn this page
Also known as P42pop
Summary
MYPOP (Myb related transcription factor, partner of profilin, HGNC:20178) is a protein-coding gene on chromosome 19q13.32, encoding Myb-related transcription factor, partner of profilin (Q86VE0). Transcriptional repressor; DNA-binding protein that specifically recognizes the core sequence 5’-YAAC[GT]G-3'.
Predicted to enable DNA-binding transcription repressor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in negative regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 339344 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 81 total
- MANE Select transcript:
NM_001012643
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:20178 |
| Approved symbol | MYPOP |
| Name | Myb related transcription factor, partner of profilin |
| Location | 19q13.32 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | P42pop |
| Ensembl gene | ENSG00000176182 |
| Ensembl biotype | protein_coding |
| OMIM | 617861 |
| Entrez | 339344 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 4 protein_coding
ENST00000322217, ENST00000904793, ENST00000904794, ENST00000904795
RefSeq mRNA: 1 — MANE Select: NM_001012643
NM_001012643
CCDS: CCDS33055
Canonical transcript exons
ENST00000322217 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001243342 | 45890023 | 45891323 |
| ENSE00001334160 | 45901275 | 45901825 |
| ENSE00001334165 | 45902570 | 45902613 |
Expression profiles
Bgee: expression breadth ubiquitous, 180 present calls, max score 90.46.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 12.4588 / max 76.0922, expressed in 1796 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 181586 | 12.1640 | 1793 |
| 181588 | 0.1485 | 69 |
| 181587 | 0.1464 | 65 |
Top tissues by expression
237 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| oocyte | CL:0000023 | 90.46 | gold quality |
| ileal mucosa | UBERON:0000331 | 90.14 | gold quality |
| tibialis anterior | UBERON:0001385 | 88.43 | silver quality |
| right frontal lobe | UBERON:0002810 | 87.94 | gold quality |
| secondary oocyte | CL:0000655 | 87.70 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 86.91 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 86.48 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 85.15 | gold quality |
| prefrontal cortex | UBERON:0000451 | 84.89 | gold quality |
| apex of heart | UBERON:0002098 | 84.65 | gold quality |
| frontal cortex | UBERON:0001870 | 84.61 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 84.44 | gold quality |
| neocortex | UBERON:0001950 | 84.36 | gold quality |
| gastrocnemius | UBERON:0001388 | 84.29 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 83.70 | gold quality |
| muscle of leg | UBERON:0001383 | 83.25 | gold quality |
| cerebral cortex | UBERON:0000956 | 83.11 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 83.11 | gold quality |
| granulocyte | CL:0000094 | 83.01 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 82.85 | gold quality |
| amygdala | UBERON:0001876 | 82.67 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 82.50 | gold quality |
| cerebellar cortex | UBERON:0002129 | 82.44 | gold quality |
| postcentral gyrus | UBERON:0002581 | 81.94 | gold quality |
| nucleus accumbens | UBERON:0001882 | 81.70 | gold quality |
| cerebellum | UBERON:0002037 | 81.67 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 81.56 | gold quality |
| putamen | UBERON:0001874 | 81.44 | gold quality |
| forebrain | UBERON:0001890 | 81.32 | gold quality |
| Ammon’s horn | UBERON:0001954 | 81.06 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.87 |
Regulation
Is transcription factor: yes
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA2535.1 | MYPOP | Myb-SANT |
JASPAR matrix evidence (PMIDs): PMID:39605530
miRNA regulators (miRDB)
47 targeting MYPOP, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4692 | 100.00 | 67.32 | 2066 |
| HSA-MIR-4673 | 100.00 | 66.64 | 1490 |
| HSA-MIR-4514 | 99.99 | 67.10 | 1870 |
| HSA-MIR-4645-5P | 99.98 | 65.81 | 1284 |
| HSA-MIR-6825-5P | 99.96 | 69.81 | 3431 |
| HSA-MIR-6809-3P | 99.91 | 71.45 | 3814 |
| HSA-MIR-1297 | 99.91 | 73.41 | 3162 |
| HSA-MIR-4753-3P | 99.90 | 71.03 | 3786 |
| HSA-MIR-4731-5P | 99.89 | 67.23 | 2537 |
| HSA-MIR-3919 | 99.87 | 69.45 | 2489 |
| HSA-MIR-10395-5P | 99.86 | 67.35 | 676 |
| HSA-MIR-6515-3P | 99.82 | 68.19 | 1933 |
| HSA-MIR-26A-5P | 99.78 | 73.52 | 2303 |
| HSA-MIR-26B-5P | 99.78 | 73.51 | 2305 |
| HSA-MIR-6763-5P | 99.76 | 64.68 | 1767 |
| HSA-MIR-3150A-3P | 99.76 | 64.44 | 1640 |
| HSA-MIR-2116-3P | 99.74 | 64.32 | 889 |
| HSA-MIR-3175 | 99.65 | 66.30 | 2031 |
| HSA-MIR-6715B-5P | 99.64 | 69.63 | 1420 |
| HSA-MIR-4269 | 99.55 | 69.89 | 1373 |
| HSA-MIR-4441 | 99.49 | 66.56 | 3216 |
| HSA-MIR-940 | 99.37 | 66.14 | 2064 |
| HSA-MIR-135A-5P | 99.36 | 71.85 | 1601 |
| HSA-MIR-135B-5P | 99.36 | 71.63 | 1613 |
| HSA-MIR-532-3P | 99.34 | 65.76 | 1195 |
| HSA-MIR-6808-5P | 99.31 | 66.23 | 2150 |
| HSA-MIR-6893-5P | 99.31 | 66.25 | 2119 |
| HSA-MIR-4270 | 99.02 | 66.26 | 1987 |
| HSA-MIR-4742-5P | 98.89 | 68.41 | 1542 |
| HSA-MIR-4755-3P | 98.77 | 65.59 | 1915 |
Cross-species orthologs
1 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Mypop | ENSMUSG00000048481 |
Protein
Protein identifiers
Myb-related transcription factor, partner of profilin — Q86VE0 (reviewed: Q86VE0)
Alternative names: Myb-related protein p42POP, Partner of profilin
All UniProt accessions (1): Q86VE0
UniProt curated annotations — full annotation on UniProt →
Function. Transcriptional repressor; DNA-binding protein that specifically recognizes the core sequence 5’-YAAC[GT]G-3’. Dimerization with PFN1 reduces its DNA-binding capacity.
Subunit / interactions. Interacts with PFN1. Homodimer and heterodimer with PFN1.
Subcellular location. Nucleus.
Domain organisation. The proline-rich region is required for PFN1 interaction.
RefSeq proteins (1): NP_001012661* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001005 | SANT/Myb | Domain |
| IPR028002 | Myb_DNA-bind_5 | Domain |
| IPR052870 | Myb-related_repressor | Family |
Pfam: PF13873
UniProt features (16 total): compositionally biased region 7, region of interest 4, short sequence motif 3, chain 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q86VE0-F1 | 65.80 | 0.21 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 60 (showing top):
GSE45365_NK_CELL_VS_CD8A_DC_DN, AAGCCAT_MIR135A_MIR135B, PATIL_LIVER_CANCER, GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GOBP_NEGATIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_II, GOBP_NEGATIVE_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_METABOLIC_PROCESS, GOMF_DNA_BINDING_TRANSCRIPTION_REPRESSOR_ACTIVITY, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, EBNA1BP2_TARGET_GENES, ID2_TARGET_GENES, SALL4_TARGET_GENES, ZNF282_TARGET_GENES, MIR135A_5P, MIR135B_5P
GO Biological Process (2): negative regulation of transcription by RNA polymerase II (GO:0000122), regulation of transcription by RNA polymerase II (GO:0006357)
GO Molecular Function (7): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227), identical protein binding (GO:0042802), DNA binding (GO:0003677), DNA-binding transcription factor activity (GO:0003700), protein binding (GO:0005515)
GO Cellular Component (1): nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 3 |
| regulation of transcription by RNA polymerase II | 2 |
| transcription by RNA polymerase II | 2 |
| regulation of DNA-templated transcription | 2 |
| negative regulation of DNA-templated transcription | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| negative regulation of transcription by RNA polymerase II | 1 |
| DNA-binding transcription factor activity, RNA polymerase II-specific | 1 |
| DNA-binding transcription repressor activity | 1 |
| protein binding | 1 |
| nucleic acid binding | 1 |
| transcription cis-regulatory region binding | 1 |
| transcription regulator activity | 1 |
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
252 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| MYPOP | PFN1 | P07737 | 622 |
| MYPOP | XPO6 | Q96QU8 | 432 |
| MYPOP | EIF4E3 | Q8N5X7 | 379 |
| MYPOP | PFN4 | Q8NHR9 | 359 |
| MYPOP | PFN3 | P60673 | 356 |
| MYPOP | GSDMC | Q9BYG8 | 351 |
| MYPOP | EMID1 | Q96A84 | 349 |
| MYPOP | MKRN1 | Q9UHC7 | 331 |
| MYPOP | SNN | O75324 | 327 |
| MYPOP | PFN2 | P35080 | 326 |
| MYPOP | R3HDM1 | Q15032 | 311 |
| MYPOP | CNNM2 | Q9H8M5 | 296 |
| MYPOP | YLPM1 | P49750 | 294 |
| MYPOP | ZNF318 | Q5VUA4 | 278 |
| MYPOP | DEFA5 | Q01523 | 255 |
IntAct
122 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MYPOP | PRR3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NECAB2 | MYPOP | psi-mi:“MI:0915”(physical association) | 0.560 |
| HNRNPK | MYPOP | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT40 | MYPOP | psi-mi:“MI:0915”(physical association) | 0.560 |
| KHDRBS3 | MYPOP | psi-mi:“MI:0915”(physical association) | 0.560 |
| MTUS2 | MYPOP | psi-mi:“MI:0915”(physical association) | 0.560 |
| SAT1 | MYPOP | psi-mi:“MI:0915”(physical association) | 0.560 |
| RBMY1A1 | MYPOP | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRA2B | MYPOP | psi-mi:“MI:0915”(physical association) | 0.560 |
| MYPOP | MDFI | psi-mi:“MI:0915”(physical association) | 0.560 |
| MYPOP | CARD10 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RBMX | MYPOP | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP12-2 | MYPOP | psi-mi:“MI:0915”(physical association) | 0.560 |
| NCK2 | MYPOP | psi-mi:“MI:0915”(physical association) | 0.560 |
| TNS2 | MYPOP | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP1-3 | MYPOP | psi-mi:“MI:0915”(physical association) | 0.560 |
| TGM1 | MYPOP | psi-mi:“MI:0915”(physical association) | 0.560 |
| RBPMS2 | MYPOP | psi-mi:“MI:0915”(physical association) | 0.560 |
| CYSRT1 | MYPOP | psi-mi:“MI:0915”(physical association) | 0.560 |
| MYPOP | KRTAP10-8 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FHL3 | MYPOP | psi-mi:“MI:0915”(physical association) | 0.560 |
| SYNCRIP | MYPOP | psi-mi:“MI:0915”(physical association) | 0.560 |
| HNRNPH1 | MYPOP | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP10-7 | MYPOP | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP19-6 | MYPOP | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP5-6 | MYPOP | psi-mi:“MI:0915”(physical association) | 0.560 |
| CIB4 | MYPOP | psi-mi:“MI:0915”(physical association) | 0.560 |
| HOXA1 | MYPOP | psi-mi:“MI:0915”(physical association) | 0.560 |
| MYPOP | PRDM14 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (55): MYPOP (Affinity Capture-MS), MYPOP (Affinity Capture-MS), MYPOP (Two-hybrid), MYPOP (Two-hybrid), MYPOP (Two-hybrid), MYPOP (Two-hybrid), MYPOP (Two-hybrid), MYPOP (Two-hybrid), MYPOP (Two-hybrid), MYPOP (Two-hybrid), MYPOP (Two-hybrid), MYPOP (Two-hybrid), MYPOP (Two-hybrid), MYPOP (Two-hybrid), MYPOP (Two-hybrid)
ESM2 similar proteins: A0A0U1RQ45, A0A1B0GWB2, A2A9T0, A6QPA0, A7MCY6, D3ZFB6, E9PUL5, E9Q0B3, F5GYI3, F5H4A9, J3QNX5, O70142, P0C1G7, P81408, P97764, P98077, Q148V8, Q15654, Q2KI80, Q3SX26, Q3SZL6, Q4V9L6, Q5FVJ4, Q5FW56, Q5RAC1, Q5T7N3, Q6DG50, Q6PAJ3, Q6PJ61, Q6ZMQ8, Q6ZNR0, Q6ZRV2, Q75VX8, Q7Z6L0, Q86UK7, Q86VE0, Q8BGW2, Q8BRJ3, Q8BX43, Q8C0R7
Diamond homologs: Q08B72, Q86VE0, Q8R4U1
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 41 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Keratinization | 11 | 23.6× | 3e-11 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| regulation of alternative mRNA splicing, via spliceosome | 5 | 45.2× | 2e-05 |
| mRNA splicing, via spliceosome | 5 | 17.0× | 6e-04 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
81 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 77 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
407 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:45891319:TGTAT:T | acceptor_gain | 1.0000 |
| 19:45891320:GTAT:G | acceptor_gain | 1.0000 |
| 19:45891321:TAT:T | acceptor_gain | 1.0000 |
| 19:45891322:AT:A | acceptor_gain | 1.0000 |
| 19:45891323:TCT:T | acceptor_loss | 1.0000 |
| 19:45891324:C:CC | acceptor_gain | 1.0000 |
| 19:45891324:C:T | acceptor_loss | 1.0000 |
| 19:45891325:T:A | acceptor_loss | 1.0000 |
| 19:45891326:G:C | acceptor_gain | 0.9900 |
| 19:45891326:G:GC | acceptor_gain | 0.9900 |
| 19:45901270:CTCA:C | donor_loss | 0.9900 |
| 19:45901271:TCA:T | donor_loss | 0.9900 |
| 19:45901272:CA:C | donor_loss | 0.9900 |
| 19:45901273:A:C | donor_loss | 0.9900 |
| 19:45901274:C:CA | donor_loss | 0.9900 |
| 19:45901273:A:AC | donor_gain | 0.9800 |
| 19:45901274:C:CC | donor_gain | 0.9800 |
| 19:45901274:CCTG:C | donor_gain | 0.9800 |
| 19:45891320:GTATC:G | acceptor_gain | 0.9700 |
| 19:45891321:TATCT:T | acceptor_gain | 0.9700 |
| 19:45891322:ATCTG:A | acceptor_gain | 0.9700 |
| 19:45891323:TCTGT:T | acceptor_gain | 0.9700 |
| 19:45891324:CTGT:C | acceptor_gain | 0.9600 |
| 19:45891325:T:G | acceptor_gain | 0.9500 |
| 19:45895527:T:C | donor_gain | 0.9500 |
| 19:45902568:A:AC | donor_gain | 0.9400 |
| 19:45902569:C:CC | donor_gain | 0.9400 |
| 19:45902563:CACT:C | donor_loss | 0.9300 |
| 19:45902564:ACTC:A | donor_loss | 0.9300 |
| 19:45902565:CTCA:C | donor_loss | 0.9300 |
AlphaMissense
2489 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:45901522:C:A | K84N | 1.000 |
| 19:45901522:C:G | K84N | 1.000 |
| 19:45901524:T:C | K84E | 1.000 |
| 19:45901529:T:A | D82V | 1.000 |
| 19:45901529:T:C | D82G | 1.000 |
| 19:45901529:T:G | D82A | 1.000 |
| 19:45901530:C:G | D82H | 1.000 |
| 19:45901534:C:A | W80C | 1.000 |
| 19:45901534:C:G | W80C | 1.000 |
| 19:45901535:C:G | W80S | 1.000 |
| 19:45901536:A:G | W80R | 1.000 |
| 19:45901536:A:T | W80R | 1.000 |
| 19:45901539:G:T | R79S | 1.000 |
| 19:45901542:T:C | K78E | 1.000 |
| 19:45901563:G:T | R71S | 1.000 |
| 19:45901606:C:A | W56C | 1.000 |
| 19:45901606:C:G | W56C | 1.000 |
| 19:45901607:C:G | W56S | 1.000 |
| 19:45901608:A:G | W56R | 1.000 |
| 19:45901608:A:T | W56R | 1.000 |
| 19:45901691:A:G | L28P | 1.000 |
| 19:45901691:A:T | L28Q | 1.000 |
| 19:45901703:T:A | E24V | 1.000 |
| 19:45901714:G:C | F20L | 1.000 |
| 19:45901714:G:T | F20L | 1.000 |
| 19:45901715:A:C | F20C | 1.000 |
| 19:45901715:A:G | F20S | 1.000 |
| 19:45901716:A:G | F20L | 1.000 |
| 19:45901510:C:A | K88N | 0.999 |
| 19:45901510:C:G | K88N | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000101153 (19:45902740 T>C,G), RS1000121350 (19:45894425 T>C), RS1000466884 (19:45894635 C>T), RS1000687419 (19:45899400 A>G), RS1000942052 (19:45889754 A>C), RS1001139379 (19:45901866 T>C,G), RS1001202556 (19:45899152 G>A), RS1001219501 (19:45894292 T>C), RS1001296159 (19:45894563 G>A), RS1001363725 (19:45897125 G>A), RS1001417410 (19:45890057 C>T), RS1001421339 (19:45902718 GC>G), RS1001571189 (19:45899833 T>G), RS1001798182 (19:45893405 C>A,G,T), RS1001809144 (19:45899561 C>A,T)
Disease associations
OMIM: gene MIM:617861 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST009798_38 | Asthma | 2.000000e-10 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
23 total (human), top 23 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Cisplatin | affects expression, affects cotreatment, increases expression | 2 |
| FR900359 | increases phosphorylation | 1 |
| bisphenol F | increases expression | 1 |
| dicrotophos | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| methylparaben | increases expression | 1 |
| sodium arsenite | increases expression | 1 |
| butyraldehyde | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| abrine | decreases expression | 1 |
| jinfukang | affects cotreatment, increases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Decitabine | affects expression | 1 |
| Sunitinib | increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Dichlorodiphenyl Dichloroethylene | decreases expression | 1 |
| Diuron | decreases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Smoke | decreases expression | 1 |
| Thiram | increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Tunicamycin | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.